Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-12-22
pubmed:abstractText
Recent in vitro evidence shows a role of endothelial nitric oxide (NO) in the modulation of isoproterenol-induced vasorelaxation. To elucidate roles of endothelial cells and NO in cyclic adenosine monophosphate (cAMP)-mediated vasodilators we examined the effects of removal of endothelium and a NO synthase (NOS) inhibitor on relaxant responses in vitro of rat aortic strips to beta-adrenoceptor stimulants and colforsin dapropate, a water-soluble forskolin, and changes in cAMP and cyclic guanosine monophosphate (cGMP) contents. Relaxant responses of rat aorta to isoproterenol, denopamine, salbutamol, colforsin, and dibutyryl cAMP (dbcAMP) were blunted by removal of endothelial cells or treatment with NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME). Relaxant response of endothelium-intact segments to isoproterenol was associated with increases in tissue cAMP and cGMP contents. Removal of endothelium or treatment with L-NAME markedly reduced basal cGMP and abolished the isoproterenol-induced increase in cGMP but not cAMP content. In endothelium-removed segments, pretreatment with sodium nitroprusside (SNP) restored the diminished relaxant response to isoproterenol and increased basal cGMP (from 0.08 +/- 0.01 to 0.16 +/- 0.02 pmol/mg protein), whereas it did not affect the isoproterenol-induced increase in cAMP. The diminished relaxant response of endothelium-removed segments to dbcAMP was not restored by SNP pretreatment. The results suggest that relaxant response of rat aorta to cAMP-mediated vasodilators is mediated, in part, by NO production in endothelium and subsequent increase in cGMP in vascular smooth-muscle cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0160-2446
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
543-51
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9781922-Adrenergic beta-Agonists, pubmed-meshheading:9781922-Animals, pubmed-meshheading:9781922-Cyclic AMP, pubmed-meshheading:9781922-Cyclic GMP, pubmed-meshheading:9781922-Drug Interactions, pubmed-meshheading:9781922-Endothelium, Vascular, pubmed-meshheading:9781922-Enzyme Inhibitors, pubmed-meshheading:9781922-Isoproterenol, pubmed-meshheading:9781922-Male, pubmed-meshheading:9781922-Muscle, Smooth, Vascular, pubmed-meshheading:9781922-NG-Nitroarginine Methyl Ester, pubmed-meshheading:9781922-Nitric Oxide, pubmed-meshheading:9781922-Nitric Oxide Synthase, pubmed-meshheading:9781922-Pulmonary Artery, pubmed-meshheading:9781922-Rats, pubmed-meshheading:9781922-Rats, Wistar, pubmed-meshheading:9781922-Receptors, Adrenergic, beta, pubmed-meshheading:9781922-Thoracic Arteries, pubmed-meshheading:9781922-Vasodilation
pubmed:year
1998
pubmed:articleTitle
Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.
pubmed:affiliation
Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Hachioji, Japan.
pubmed:publicationType
Journal Article, Comparative Study